secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZEVRA THERAPEUTICS, INC. (ZVRA)
CIK:        0001434647
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001434647-25-000018
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zevra appoints Timothy Sangiovanni as interim CFO effective Jan 1, 2026
-----------------------------------------------------------------------

- Timothy Sangiovanni named interim principal financial officer, effective January 1, 2026.
- Sangiovanni currently serves as SVP Finance and Corporate Controller; joined company in 2015.
- No change in compensation arrangements in connection with the appointment.
- No information provided on predecessor's departure or timing of permanent CFO search.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434647/000143464725000018/0001434647-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434647/000143464725000018/zvra-20251211.htm
  HTML page:      https://secwatch.observer/filing/0001434647-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer